A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.

A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia. Biol Blood Marrow Transplant. 2013 Jul; 19(7):1040-5.

View in: PubMed

subject areas

Adult
Aged
Busulfan
Case-Control Studies
Cytarabine
Daunorubicin
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Myeloablative Agonists
Prognosis
Recurrence
Survival Analysis
Transplantation Conditioning
Transplantation, Homologous
Vidarabine

authors with profiles

Koen Van Besien